Clinical trial
The Optimal Mode of Renal Replacement Therapy in Acute Kidney Injury (OMAKI) Study: A Pilot Randomized Controlled Trial of Convective Versus Diffusive Clearance
NCT00675818 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Optimal Mode of Renal Replacement Therapy in Acute Kidney Injury (OMAKI) Study: A Pilot Randomized Controlled Trial of Convective Versus Diffusive Clearance
- Lead sponsor
- Unity Health Toronto
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 31, 2008
- Completion date
- October 31, 2010
- Enrollment
- 78 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.